Evidence map›Paper›PMID 26808720›Full record

ArticlePharmaceutical biology2016

Biological activity of terpene compounds produced by biotechnological methods.

Roman Paduch, Mariusz Trytek, Sylwia K Król, Joanna Kud, Maciej Frant, Martyna Kandefer-Szerszeń, Jan Fiedurek

Open access · bronzeAbstract read
In one paragraph

Article in Pharmaceutical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Chemical Composition and Anti-Lung Cancer Activities ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Synthesis of conjugates of (aRussian chemical bulletin = Izvestiia Akademii nauk. Seriia khimicheskaia · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Roman Paducha Department of Virology and Immunology , Institute of Microbiology and Biotechnology, Maria Curie-Skłodowska University , Lublin , Poland ;
Mariusz Trytekb Department of Industrial Microbiology , Institute of Microbiology and Biotechnology, Maria Curie-Skłodowska University , Lublin , Poland.
Sylwia K Króla Department of Virology and Immunology , Institute of Microbiology and Biotechnology, Maria Curie-Skłodowska University , Lublin , Poland ;
Joanna Kuda Department of Virology and Immunology , Institute of Microbiology and Biotechnology, Maria Curie-Skłodowska University , Lublin , Poland ;
Maciej Franta Department of Virology and Immunology , Institute of Microbiology and Biotechnology, Maria Curie-Skłodowska University , Lublin , Poland ;
Martyna Kandefer-Szerszeńa Department of Virology and Immunology , Institute of Microbiology and Biotechnology, Maria Curie-Skłodowska University , Lublin , Poland ;
Jan Fiedurekb Department of Industrial Microbiology , Institute of Microbiology and Biotechnology, Maria Curie-Skłodowska University , Lublin , Poland.
Maria Curie-Skłodowska University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextBiotransformation systems are profitable tools for structural modification of bioactive natural compounds into valuable biologically active terpenoids.

objectiveThis study determines the biological effect of (R)-(+)-limonene and (-)-α-pinene, and their oxygenated derivatives, (a) perillyl alcohol and (S)-(+)- and (R)-(-)-carvone enantiomers and (b) linalool, trans-verbenol and verbenone, respectively, on human colon tumour cells and normal colonic epithelium. MATERIALS AND

methodsBiotransformation procedures and in vitro cell culture tests were used in this work. Cells were incubated for 24 h with terpenes at concentrations of 5-500 μg/mL for NR, MTT, DPPH, and NO assays. IL-6 was determined by ELISA with/without 2 h pre-activation with 10 μg/mL LPS.

resultstrans-Verbenol and perillyl alcohol, obtained via biotransformation, produced in vitro effect against tumour cells at lower concentrations (IC50 value = 77.8 and 98.8 μg/mL, respectively) than their monoterpene precursors, (R)-(+)-limonene (IC50 value = 171.4 μg/mL) and (-)-α-pinene (IC50 value = 206.3 μg/mL). They also showed lower cytotoxicity against normal cells (IC50 > 500 and > 200 μg/mL, respectively). (S)-(+)-Carvone was 59.4% and 27.1% more toxic to tumour and normal cells, respectively, than the (R)-(-)-enantiomer. (R)-(+)-limonene derivatives decreased IL-6 production from normal cells in media with or without LPS (30.2% and 13.9%, respectively), while (-)-α-pinene derivatives induced IL-6 (verbenone had the strongest effect, 60.2% and 29.1% above control, respectively). None of the terpenes had antioxidative activity below 500 μg/mL. DISCUSSION AND

conclusionsBioactivity against tumour cells decreased in the following order: alcohols > ketones > hydrocarbons. (R)-(+)-limonene, (-)-α-pinene, and their derivatives expressed diverse activity towards normal and tumour cells with noticeable enantiomeric differences.

Indexed as

Antineoplastic AgentsBiotechnologyBiotransformationBiphenyl CompoundsCell SurvivalChrysosporiumColonDrug DiscoveryHT29 CellsHumansIntestinal MucosaMortierellaNitric OxidePicratesTerpenes1,1-diphenyl-2-picrylhydrazylAntineoplastic AgentsBiphenyl CompoundsNitric OxidePicratesTerpenesColon canceressential oilsfree radicals scavengingterpenestoxicity

Identifiers

PMID26808720
PMCPMC11133002
OpenAlexW2267214493

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.